Parallel vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-10
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionParallelIsomorphic Labs
PricingContact salesContact sales
Target UsersHospital coding/billing departmentsLarge pharma companies
Core TechnologyGenerative AI for medical codingAlphaFold + AI drug design engine
DeploymentRemote VPN/RPA, no EHR integration neededPartnership-based, no self-service
Key PartnersHospital systemsNovartis, Johnson & Johnson
Parallel
Parallel

Parallel builds AI agents that automate hospital medical coding, connecting to existing EHR systems via VPN and RPA instead of custom integration projects.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs is an AI-first drug discovery company that designs novel molecules and predicts candidate performance in pharma research collaborations.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
5 views
7.5k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
—
Categories
🧾 Healthcare Revenue Cycle
🧬 Drug Discovery & Life Sciences
Features
Agent n°01 Medical Coding for hospital coding teams
Automated medical coding for simple inpatient cases
Automated medical coding for simple outpatient cases
Smart coding suggestions for complex patient stays that coders review
Generative AI reads unstructured clinical documentation and patient context
Applies coding standards plus hospital-specific rules
ICD-10 coding accuracy roughly doubled in the September 2026 engine upgrade
Procedure coding added in the September 2026 engine upgrade
Data analysis capability added to the Parallel assistant (October 2026)
Connects to existing hospital systems through remote VPN access
Connects via Robotic Process Automation (RPA) operating the same systems a human would
No custom EHR API integration project required
Works side by side with hospital coding teams
Health data hosted in the EU by HDS-certified infrastructure providers, in line with GDPR
Hospital data not used to train the underlying models
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Built on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO

Who should pick which

  • Hospital CFO
    Pick: Parallel

    Parallel directly targets hospital revenue cycle management by improving coding accuracy and speed, leading to optimized reimbursement. Its easy deployment via VPN/RPA minimizes IT overhead.

  • Pharma R&D Executive
    Pick: Isomorphic Labs

    Isomorphic Labs' AI-first drug design engine and AlphaFold expertise are ideal for large-scale drug discovery programs, as evidenced by its partnerships with Novartis and Johnson & Johnson.

  • Hospital IT Director
    Pick: Parallel

    Parallel requires no direct API or EHR integration, reducing IT burden. Its compliance with EU data regulations and no-training-on-data policy makes it safe for hospital environments.

  • Venture Capitalist in biotech
    Pick: Isomorphic Labs

    Isomorphic Labs' $600M investment and Series B indicate strong confidence and capital efficiency in AI drug discovery, making it a compelling portfolio company.

  • Small clinic administrator
    Pick: Parallel

    Though Parallel is best for higher coding volumes, its automated simple-case handling could still benefit clinics that grow; but with contact pricing, it may not suit very low volumes.

Frequently Asked Questions

Can I use Isomorphic Labs as an individual researcher?

No, Isomorphic Labs operates solely through deep pharma partnerships; it does not offer a self-service product or API for individual use.

Does Parallel integrate with my existing EHR?

Parallel does not require direct EHR integration; it uses remote VPN and RPA to access your systems just like a human coder would.

How recent is Isomorphic Labs' latest funding?

Isomorphic Labs closed a Series B round in February 2026 (announced May 2026); prior to that, it raised a $600M external round in March 2025.

Is Parallel's AI trained on hospital data?

No, Parallel does not train on hospital data. It uses generative AI models tailored with coding standards and hospital-specific rules, but your data remains private.

What domains do these tools cover?

Parallel is for healthcare administrative tasks (medical coding). Isomorphic Labs is for drug discovery (therapeutic design). They don't overlap.

Can I get a free trial?

Both tools require contacting sales for pricing and trial availability; no public free tiers exist.

Which companies partner with Isomorphic Labs?

Isomorphic Labs has research collaborations with Novartis and Johnson & Johnson (announced Jan 2026).

How does Parallel ensure data compliance?

Parallel complies with RGPD, HDS, and ISO 27001. Data is hosted in the EU, and deployment uses remote VPN/RPA without storing data in external systems.

More Parallel or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026